Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial

PURPOSE: To investigate the safety and toxicity of percutaneous hepatic perfusion with melphalan (M-PHP) with the Delcath Systems’ second-generation (GEN 2) filter and compare the outcomes with historical data from studies using the first-generation filter. MATERIALS AND METHODS: A prospective, sing...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Intervent Radiol
Auteurs principaux: Meijer, T. Susanna, Burgmans, Mark C., Fiocco, Marta, de Geus-Oei, Lioe-Fee, Kapiteijn, Ellen, de Leede, Eleonora M., Martini, Christian H., van der Meer, Rutger W., Tijl, Fred G. J., Vahrmeijer, Alexander L.
Format: Artigo
Langue:Inglês
Publié: Springer US 2019
Sujets:
Clinical Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6502784/
https://ncbi.nlm.nih.gov/pubmed/30767147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00270-019-02177-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires